Northland Capital Markets has initiated coverage on Mirion Technologies Inc (MIR), assigning the company an Outperform rating. This marks the firm's first assessment of Mirion's investment potential based on its analysis of the business and industry dynamics.
Mirion Technologies, headquartered in Atlanta, Georgia, specializes in radiation safety, science, and medicine. The company operates in the electrical equipment sector and employs 2,860 full-time staff. It went public on June 29, 2020. Mirion's offerings include products and services in two segments: Nuclear & Safety and Medical. The Medical segment focuses on radiation therapy, nuclear medicine, and personal dosimetry, while the Nuclear & Safety segment addresses critical radiation safety applications across various industries, including nuclear energy and defense.
As of November 20, 2025, Mirion's market capitalization stands at $5.9 billion, with a P/E ratio of 223.44 and an EPS of $0.12. The company is set to report its next earnings on July 29, 2026, with an estimated EPS of $0.13 and revenue of $261.5 million.
Analyst ratings provide professional insights based on research. While they can inform investment decisions, they should be considered alongside other factors such as company fundamentals and market trends. Analyst opinions may evolve as new information becomes available.
This update provides insight into the current sentiment surrounding Mirion Technologies, with the analyst consensus reflecting a Buy rating across 11 total ratings, including 3 Strong Buy and 7 Buy ratings.